1. Home
  2. ALZN vs TCTM Comparison

ALZN vs TCTM Comparison

Compare ALZN & TCTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALZN
  • TCTM
  • Stock Information
  • Founded
  • ALZN 2016
  • TCTM 2002
  • Country
  • ALZN United States
  • TCTM China
  • Employees
  • ALZN N/A
  • TCTM N/A
  • Industry
  • ALZN Medicinal Chemicals and Botanical Products
  • TCTM Other Consumer Services
  • Sector
  • ALZN Health Care
  • TCTM Real Estate
  • Exchange
  • ALZN Nasdaq
  • TCTM Nasdaq
  • Market Cap
  • ALZN 6.9M
  • TCTM 7.7M
  • IPO Year
  • ALZN 2021
  • TCTM 2014
  • Fundamental
  • Price
  • ALZN $1.66
  • TCTM $1.43
  • Analyst Decision
  • ALZN
  • TCTM
  • Analyst Count
  • ALZN 0
  • TCTM 0
  • Target Price
  • ALZN N/A
  • TCTM N/A
  • AVG Volume (30 Days)
  • ALZN 271.9K
  • TCTM 613.1K
  • Earning Date
  • ALZN 09-11-2024
  • TCTM 10-15-2024
  • Dividend Yield
  • ALZN N/A
  • TCTM N/A
  • EPS Growth
  • ALZN N/A
  • TCTM N/A
  • EPS
  • ALZN N/A
  • TCTM 0.11
  • Revenue
  • ALZN N/A
  • TCTM $193,937,582.00
  • Revenue This Year
  • ALZN N/A
  • TCTM $99.90
  • Revenue Next Year
  • ALZN N/A
  • TCTM N/A
  • P/E Ratio
  • ALZN N/A
  • TCTM $8.47
  • Revenue Growth
  • ALZN N/A
  • TCTM N/A
  • 52 Week Low
  • ALZN $1.40
  • TCTM $0.74
  • 52 Week High
  • ALZN $34.50
  • TCTM $2.99
  • Technical
  • Relative Strength Index (RSI)
  • ALZN 39.08
  • TCTM 60.76
  • Support Level
  • ALZN $1.55
  • TCTM $1.32
  • Resistance Level
  • ALZN $1.68
  • TCTM $1.90
  • Average True Range (ATR)
  • ALZN 0.14
  • TCTM 0.26
  • MACD
  • ALZN 0.05
  • TCTM 0.07
  • Stochastic Oscillator
  • ALZN 60.47
  • TCTM 54.40

About ALZN Alzamend Neuro Inc.

Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.

About TCTM Tarena International Inc.

TCTM Kids IT Education Inc engages in the provision of IT-focused education services in Mainland China. The company has a single reportable segment: IT-focused Supplementary STEM Education Services. It offers supplementary science, technology, engineering, and mathematics (STEM) education programs to young children aged between three and eighteen through online teaching models and instructors from online or offline learning centers. The company also operates an education platform that offers distance instruction, classroom-based learning, and online learning modules.

Share on Social Networks: